Back to Candriam S.C.A.

VRTX
Showing 8 of 29 quarters

Position history for Candriam S.C.A.'s holdings in VERTEX PHARMACEUTICALS INC

Candriam S.C.A. holds 228,915 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $102.2M as of 2026-Q1. The position was increased (+1.6% shares). VRTX represents 0.5% of Candriam S.C.A.'s portfolio.

Current Value

$102.2M

Current Shares

228,915

Total Value Change

-$51.6M

Total Shares Change

-99,356

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
228,915
+1.6%
$102.2M0.5%$474.27
43
2025-Q4
Increased
225,292
+29.1%
$102.1M0.5%$453.74
53
2025-Q3
Decreased
174,567
-1.0%
$68.4M0.4%$395.31
0
2025-Q2
Decreased
176,398
-11.0%
$78.5M0.5%$441.30
0
2025-Q1
Decreased
198,287
-23.3%
$96.1M0.6%$492.69
0
2024-Q4
Decreased
258,622
-16.9%
$104.1M0.6%$399.35
0
2024-Q3
Decreased
311,307
-5.2%
$144.8M0.8%$462.88
0
2024-Q2
Decreased
328,271
-15.5%
$153.9M0.9%$468.72
0

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used